Overview
Clinical Meaning
Antibiotic stewardship at the clinician prescriptive level requires deep understanding of resistance mechanisms, pharmacokinetic/pharmacodynamic (PK/PD) optimization, and eviden...
WHNP
WHNP
Antibiotic stewardship at the clinician prescriptive level requires deep understanding of resistance mechanisms, pharmacokinetic/pharmacodynamic (PK/PD) optimization, and evidence-based prescribing. Key resistance mechanisms include: ESBL-producing Enterobacterales (plasmid-mediated CTX-M enzymes hydrolyzing third-generation cephalosporins), carbapenem-resistant Enterobacterales (CRE via KPC, NDM, OXA-48 enzymes), MRSA (mecA gene encoding PBP2a with reduced beta-lactam affinity), and vancomycin-resistant Enterococcus (vanA/vanB gene clusters). PK/PD targets drive dosing: time-dependent antibiotics (beta-lactams) target fT>MIC >40-70%, concentration-dependent antibiotics (aminoglycosides) target Cmax/MIC >10, and AUC-dependent antibiotics (vancomycin, fluoroquinolones) target AUC/MIC ratios. The clinician must select empiric therapy based on local antibiograms, optimize dosing using PK/PD principles, de-escalate based on culture data, determine appropriate duration, and implement stewardship quality metrics.
Unlock full lesson + practice questions
4 more sections with scenarios, priorities, and review drills.
Next study step
Finish the lesson first, then choose a focused activity to apply what you just reviewed.
Continue studying
Sign in to save progress on this lesson.
Unlock the interactive lesson quiz with a plan that includes this WHNP pathway. You can still explore topic-filtered questions from the bank hubs below.